| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059873A1 Potassium channel modulators |
| 07/24/2003 | WO2003059853A1 Substituted rubenes, a kind of novel functional fluoresent material |
| 07/24/2003 | US20030139607 Antiarrhythmic agents, treating cardiovascular disorders, infarct prophylaxis, angina pectoris, shock, stroke, transplant organ surgery |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139419 Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
| 07/24/2003 | US20030139418 Substituted aryl and heteroaryl compounds as E-type prostaglandin antagonists |
| 07/24/2003 | US20030139404 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030138964 Synthesis of histamine dihydrochloride |
| 07/24/2003 | US20030138376 A compressed tablets comprising an embedded polymer matrix, insoluble and disintegrable in the solvents, removed by filtration, separation from a formed soluble product |
| 07/24/2003 | CA2700690A1 Process for producing reformatsky reagent in stable form |
| 07/23/2003 | EP1328518A1 Imidazolium salts and the use of these ionic liquids as a solvent |
| 07/23/2003 | EP1328517A2 Novel m-amino-phenylimino-imidazolidine derivatives for treating urinary incontinence |
| 07/23/2003 | EP1328272A1 Nf-kappa-b inhibitors |
| 07/23/2003 | EP0929528B1 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2003 | CN1432013A Imidazole derivatives or salts thereof and drugs contg. derivatives or salts |
| 07/23/2003 | CN1432004A Alkynyl phenyl heteroaromatic glucokinase activators |
| 07/23/2003 | CN1432000A TNF-alpha prodn. inhibitors |
| 07/23/2003 | CN1115343C Process for prepn. of (1S,4R)-or (1R,4S)-4-(2-amino-6-chloro-9H-purin-9-yl) -2-cyclopentene-1-methanol |
| 07/23/2003 | CN1115335C Process for prepn. of formylimidazoles |
| 07/23/2003 | CN1115330C N-(4-carbamimido-phenyl)-phenylglycinamid derivatives |
| 07/22/2003 | US6596877 Reaction with dimethyl carbonate using 4-(dimethylamino)pyridine, 1,4-diazabicyclo(2.2.2)octane, or 1,8-diazabicyclo(5.4.0)undec-7-ene basic catalyst |
| 07/22/2003 | US6596876 Prostaglandin I2 inhibitors |
| 07/22/2003 | US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 07/22/2003 | US6596752 Inhibitors of α4β1 mediated cell adhesion |
| 07/22/2003 | US6596746 Cyclic protein tyrosine kinase inhibitors |
| 07/22/2003 | US6596739 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 07/22/2003 | US6596738 Inhibiting activity to adenosine deaminase (hereinafter described as ADA) An adenosine deaminase inhibiting agent comprising a compound of the formula (I): |
| 07/22/2003 | US6596693 Dipeptide apoptosis inhibitors and the thereof |
| 07/22/2003 | US6596259 Iron pyrazole complex; electron transfer core encapsulated in protective shell; magnetic resonance imaging contrast agent; varying solubility by outer shell substitution |
| 07/22/2003 | US6596130 Using ionic liquids as solvents resulted in high yields with dramatically reduced reaction times |
| 07/17/2003 | WO2003057666A2 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057221A1 Optical free space signalling system |
| 07/17/2003 | WO2003057220A1 Cyclic urea derivatives with 5-ht2c receptor activity |
| 07/17/2003 | WO2003057144A2 Change inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | WO2003057135A2 Aqueous compositions containing metronidazole |
| 07/17/2003 | WO2003048119A3 Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof |
| 07/17/2003 | WO2002085861A8 Imidazolidine compounds and their use as cxcr3 antagonists |
| 07/17/2003 | US20030135063 Especially Type II diabetes; stimulating the kinase activity of the insulin receptor; activating the insulin receptor |
| 07/17/2003 | US20030134882 Use of C2-substituted indan-1-one systems for preparing medicaments for the prophylaxis or treatment of obesity |
| 07/17/2003 | US20030134881 Substituted with a thio, sulfoxy or sulfonyl group |
| 07/17/2003 | US20030134880 Novel cd23 inhibitors |
| 07/17/2003 | US20030134879 Substituted with a thio, sulfoxy or sulfonyl group |
| 07/17/2003 | US20030134856 Method and structure for inhibiting activity of serine elastases |
| 07/17/2003 | US20030134848 Substituted 1-aza-2-imino-heterocycles and their use as nicotinic acetylcholin receptors activators |
| 07/17/2003 | US20030134827 Lactams or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic amide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors. |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/16/2003 | EP1326993A2 PRODUCTION OF g(a)-HYDROXY-CARBOXYLIC ACIDS USING A COUPLED ENZYME SYSTEM |
| 07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 07/16/2003 | EP1326844A2 Process for preparation of n-substituted 2-sulfanylimidazoles |
| 07/16/2003 | EP1326827A2 Insecticidal 1,8-naphthalenedicarboxamides |
| 07/16/2003 | EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses |
| 07/16/2003 | CN1429821A Monomer containing cycloalkyleneurea and preparing polymer and emulsoid by it |
| 07/16/2003 | CN1114403C Vitronectin receptor antagonists |
| 07/15/2003 | US6593477 Synthesis of 3-acylaminopyrazoles |
| 07/15/2003 | US6593374 Such as 3-(3'4'5'-trimethoxybenzoyl)-2-(3'benzylphosphate 4'methoxyphenyl)-6-methoxybenzo(b)thiophene; functionalized to prepare phosphate esters, phosphate salts, and phosphoramidates useful as antitumor agents |
| 07/15/2003 | US6593327 Compounds and compositions as protease inhibitors |
| 07/15/2003 | US6592894 Hydrogel-isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules |
| 07/14/2003 | WO2003059878A2 Thieno (3, 2-b) pyridones as antiviral compounds |
| 07/14/2003 | CA2472960A1 Thieno (3, 2-b) pyridones as antiviral compounds |
| 07/10/2003 | WO2003056299A2 Labeling reagent and methods of use |
| 07/10/2003 | WO2003055861A1 Benzocyclodecane derivatives with antitumor activity |
| 07/10/2003 | WO2003055850A1 β-AMYLOID PROTEIN PRODUCTION/SECRETION INHIBITORS |
| 07/10/2003 | WO2003055481A1 Organ fibrosis inhibitors |
| 07/10/2003 | WO2002059267A3 Constitutively desensitized g protein-coupled receptors |
| 07/10/2003 | US20030130349 Inhibitors of alpha 4beta1 mediated cell adhesion |
| 07/10/2003 | US20030130332 Method for prophylaxis and treatment of diabetic complications with 4[alpha-hydroxy-2-methyl-5-(1-imidazolyl)benzyl]-3,5-dimethylbenzoic acid and derivatives |
| 07/10/2003 | US20030130329 Imidazolyl/benzimidazolyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
| 07/10/2003 | US20030130323 Anorectic agents |
| 07/10/2003 | US20030130287 Psychological disorders; central nervous system disorders; antidepressants; Parkinson's disease; Alzheimer's disease;cardiovascular disorders |
| 07/10/2003 | US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE) |
| 07/10/2003 | US20030130271 1,3-Diheterocyclic metalloprotease inhibitors |
| 07/10/2003 | US20030130236 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/10/2003 | US20030127129 Charge transfer material, and photoelectric conversion device and photoelectric cell using same, and pyridine compound |
| 07/10/2003 | CA2471910A1 Benzocyclodecane derivatives with antitumor activity |
| 07/09/2003 | EP1325085A1 Cationic imidazole azo dyes |
| 07/09/2003 | EP1324999A1 Novel aminophenyl piperazine or aminophenyl piperidine derivatives inhibiting prenyl transferase proteins and methods for preparing same |
| 07/09/2003 | EP1324975A2 Dynamic resolution of isomers and resolved isomers |
| 07/09/2003 | EP1324970A2 Retinoids for the treatment of emphysema |
| 07/09/2003 | EP1324741A1 Method of dyeing keratin-containing fibres |
| 07/09/2003 | EP1072588B1 Process for producing arylsulfenyl halide |
| 07/09/2003 | EP0973768B1 Azole compounds, their production and their use |
| 07/09/2003 | EP0966490B1 Catalyst compositions for the polymerization of olefins |
| 07/09/2003 | CN1429229A Hydroxylamine esters as polymerization initiators |
| 07/09/2003 | CN1429214A Synthesis procedure for biphenylimidazolyl-(1)-phenylmethane and related compounds |
| 07/09/2003 | CN1429210A Substituted thioacetamides |
| 07/09/2003 | CN1429199A Insecticidal 1,8-naphthalenedicarboxamides |
| 07/09/2003 | CN1429133A Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 07/09/2003 | CN1113881C 8-substituted-1,3,8-triaza-spiro [4.5] decan-4-on derivatives |
| 07/09/2003 | CN1113875C Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 07/09/2003 | CN1113874C Benzocycloalkylazolethione derivatives |
| 07/09/2003 | CN1113873C Novel optionally substitued phenylimidazolidines, intermediates and process for prepn. thereof, use as druge and pharmaceutical composition contg. same |
| 07/08/2003 | US6590106 Reacting an aliphatic carboxylic acid and an ammonium salt of the aliphatic carboxylic acid with an amide compound containing carbonyl and nitro groups to form an imidazole compound |
| 07/08/2003 | US6590105 For skin lightening or depigmentation; works by inhibiting tyrosinase in humans; kits |
| 07/08/2003 | US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects |
| 07/08/2003 | US6589966 A family of hexadentate Fe(II) chelators having marked antiproliferative activity against tumor cells is disclosed. The cytotoxic metal chelators and complexes of the present invention are represented by the general formula below: |
| 07/08/2003 | US6589914 Dihalopropene compounds, insecticidal/acaridcidal agents containing same, and intermediates for their production |
| 07/08/2003 | CA2264372C New benzocyclobutane compounds, their method of preparation, and pharmaceutical compositions containing them |
| 07/08/2003 | CA2260277C Imidazolate sulfuryl difluorides |